FDA Authorizes IQOS to be Marketed as Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified...
Philip Morris International’s Revenue and Stock Jumps Due to IQOS
Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S....
Philip Morris International to Regain Full U.S. Commercial Rights to IQOS
Altria has reached an agreement with Philip Morris International (PMI) relating to the IQOS Tobacco Heating System. Altria has revealed that it will receive...
FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN
22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
U.S. Senators Oppose Philip Morris International’s iQOS Application
Opposition is growing against Philip Morris International’s modified-risk application for iQOS. Ten U.S. senators–all Democrats–have sent a letter to Scott Gottlieb, the commissioner of...
Foundation For a Smoke-Free World’s Ties to Philip Morris International Questioned
The Foundation For a Smoke-Free World has sent a letter to 344 public health researchers and groups, offering $1 billion in grants. While this...
